Some serious cracks in the near-term trend cast doubt on the market's ability to continue its sharp angle of advance. More
Longstanding Dow Streak Halted — Tuesday’s IP Market Recap
Big moves down in Salesforce.com and Zynga peppered a poor day for the broader markets spurned by concerns over the Fed's future easing plans. More
It’s Hard to Win the Pharma News Game
Big news for three cancer-treatment drugs had virtually zero effect on the stocks. Here's why investors shouldn't have been surprised, and what they can learn. More
Dividend Investors: Don’t Fear the T-Note
While dividend stocks took a bit of a haircut last week amid the 10-Year Treasury's bump above a 2% yield, it's not yet time to panic about a wholesale selloff. More
3 Potential M&A Targets in the Cloud
Now that Salesforce has taken ExactTarget off the market, here are a few other cloud operators that might find themselves in M&A crosshairs. More
